MYO18B and lung carcinoma: Nishioka et al. [20] illustrated that MYO18B expression was decreased in 88% of nonsmall cell lung carcinoma and 47% of small cell lung carcinoma cell lines, and restoration of MYO18B expression can effectively suppress the growth of lung cancer cells.